We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+4.36%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$228M
AUM Growth
-$4.71M
(-2%)
Cap. Flow
-$9.77M
Cap. Flow
% of AUM
-4.3%
Top 10 Holdings %
Top 10 Hldgs %
50.06%
Holding
75
New
7
Increased
21
Reduced
24
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NeoGenomics
NEO
|
+$4.64M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$3.81M |
| 3 |
SHPG
Shire pic
SHPG
|
+$3.13M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$2.16M |
| 5 |
MacroGenics
MGNX
|
+$1.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Option Care Health
OPCH
|
+$6.12M |
| 2 |
Orthofix Medical
OFIX
|
+$5.87M |
| 3 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
+$4.76M |
| 4 |
ELGX
Endologix Inc
ELGX
|
+$3.29M |
| 5 |
CPHD
Cepheid Inc
CPHD
|
+$3.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 77.84% |
| 2 | Energy | 4.42% |
| 3 | Communication Services | 1.49% |
| 4 | Real Estate | 1.27% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NeoGenomics
NEO
$1.96B
| $22.1M | 9.69% |
2,573,891
+541,256
| +27% | +$4.64M |
|
2
AtriCure
ATRC
$1.92B
| $18.4M | 8.08% |
939,012
+9,136
| +1% | +$166K |
|
|
AKRX
3
DELISTED
Akorn Inc
AKRX
| $11.7M | 5.13% |
534,524
+8,976
| +2% | +$207K |
|
|
OXFD
4
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $11.2M | 4.91% |
747,639
+23,757
| +3% | +$333K |
|
|
LHCG
5
DELISTED
LHC Group LLC
LHCG
| $10.1M | 4.42% |
219,992
-3,008
| -1% | -$122K |
|
|
ARRY
6
DELISTED
Array Biopharma Inc
ARRY
| $8.79M | 3.86% |
1,000,361
+14,119
| +1% | +$104K |
|
|
IMMU
7
DELISTED
Immunomedics Inc
IMMU
| $8.38M | 3.68% |
2,282,009
+1,289,142
| +130% | +$3.81M |
|
8
Harvard Bioscience
HBIO
$27.5M
| $8.37M | 3.68% |
274,413
-8,138
| -3% | -$207K |
|
9
HealthStream
HSTM
$819M
| $7.62M | 3.35% |
304,300
+12,257
| +4% | +$316K |
|
|
ENTL
10
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $7.42M | 3.26% |
391,289
+120
| +0% | +$2.3K |
|
|
ENZ
11
DELISTED
Enzo Biochem, Inc.
ENZ
| $6.99M | 3.07% |
1,007,357
-40,375
| -4% | -$258K |
|
|
NXTM
12
DELISTED
NxStage Medical Inc.
NXTM
| $6.47M | 2.85% |
247,015
-3,371
| -1% | -$83.4K |
|
|
SHPG
13
DELISTED
Shire pic
SHPG
| $6.35M | 2.79% |
37,248
+17,650
| +90% | +$3.13M |
|
|
TLGT
14
DELISTED
Teligent, Inc
TLGT
| $6.33M | 2.78% |
95,769
-3,839
| -4% | -$270K |
|
|
KTWO
15
DELISTED
K2M Group Holdings, Inc
KTWO
| $5.5M | 2.42% |
274,418
-760
| -0.3% | -$14.4K |
|
16
Veracyte
VCYT
$3.7B
| $5.36M | 2.35% |
692,210
+118,431
| +21% | +$886K |
|
|
AMED
17
DELISTED
Amedisys
AMED
| $5M | 2.2% |
117,279
+4,675
| +4% | +$199K |
|
|
SAGE
18
DELISTED
Sage Therapeutics
SAGE
| $4.81M | 2.11% |
94,144
+107
| +0.1% | +$5.04K |
|
|
SPNC
19
DELISTED
Spectranetics Corp
SPNC
| $4.5M | 1.98% |
183,727
-10,284
| -5% | -$242K |
|
|
BLUE
20
DELISTED
bluebird bio
BLUE
| $4.4M | 1.93% |
5,500
+286
| +5% | +$227K |
|
|
MDCO
21
DELISTED
Medicines Co
MDCO
| $4.33M | 1.91% |
127,725
+1,701
| +1% | +$60.3K |
|
22
Ligand Pharmaceuticals
LGND
$5.76B
| $4.18M | 1.84% |
66,028
+21
| +0% | +$1.32K |
|
23
LeMaitre Vascular
LMAT
$2.32B
| $4.05M | 1.78% |
159,943
-22,691
| -12% | -$504K |
|
24
Bio-Techne
TECH
$11.2B
| $3.96M | 1.74% |
154,008
+59,056
| +62% | +$1.55M |
|
|
MODN
25
DELISTED
MODEL N, INC.
MODN
| $3.39M | 1.49% |
382,644
-12,522
| -3% | -$116K |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q4 2016 Portfolio in Review
As of Q4 2016, First Light Asset Management held 75 positions worth $228M, down 2% from $232M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
First Light Asset Management withdrew a net $9.77M in Q4 2016, closing 22 positions and reducing 24 holdings. Its most notable exit was Option Care Health, an estimated $6.12M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 78% a quarter earlier, followed by Energy and Communication Services.
Against the trend, First Light Asset Management opened a new position in iShares Biotechnology ETF worth $2.1M.
- First Light Asset Management's largest Q4 2016 buy was iShares Biotechnology ETF: 23,691 shares worth $2.1M.
- First Light Asset Management added most to NeoGenomics in Q4 2016, an estimated $4.64M increase.
- First Light Asset Management's biggest Q4 2016 reduction was LeMaitre Vascular, cutting an estimated $504K.
- First Light Asset Management fully exited Option Care Health in Q4 2016, selling an estimated $6.12M.
- First Light Asset Management's ten largest holdings make up 50% of its $228M portfolio in Q4 2016.
- First Light Asset Management opened 7 new positions and closed 22 in Q4 2016.
- First Light Asset Management's portfolio value fell 2% quarter-over-quarter to $228M.
Based on First Light Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.